Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Up – Here’s Why

Shares of Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY – Get Free Report) gapped up prior to trading on Monday. The stock had previously closed at $22.51, but opened at $23.56. Chugai Pharmaceutical shares last traded at $23.11, with a volume of 42,987 shares traded.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. UBS Group lowered Chugai Pharmaceutical from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 6th. Nomura upgraded Chugai Pharmaceutical to a “hold” rating in a research note on Tuesday, September 1st. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Chugai Pharmaceutical has an average rating of “Moderate Buy”.

View Our Latest Stock Analysis on Chugai Pharmaceutical

Chugai Pharmaceutical Stock Up 2.7%

The firm has a market capitalization of $76.06 billion, a P/E ratio of 24.07 and a beta of 0.60. The firm’s 50-day simple moving average is $20.81 and its 200-day simple moving average is $24.29.

Chugai Pharmaceutical (OTCMKTS:CHGCY – Get Free Report) last issued its quarterly earnings results on Tuesday, October 27th. The company reported $0.27 EPS for the quarter. Chugai Pharmaceutical had a net margin of 35.63% and a return on equity of 24.91%. The firm had revenue of $2.54 billion for the quarter, compared to analyst estimates of $2.29 billion. As a group, analysts expect that Chugai Pharmaceutical Co., Ltd. Unsponsored ADR will post 1.00 EPS for the current fiscal year.

Chugai Pharmaceutical Company Profile

(Get Free Report)

Chugai Pharmaceutical is a Japan-based research-driven pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its work focuses on areas including oncology, immunology, hematology and neuroscience, and its portfolio includes biologic and antibody-based medicines as well as other pharmaceutical products. The company was established in Japan in 1925 and is headquartered in Tokyo. Since 2002, Chugai has been part of the Roche Group through a strategic alliance, while continuing to operate as a Japan-based pharmaceutical company.

Recommended Stories

Receive News & Ratings for Chugai Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chugai Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.